1. Home
  2. SCLXW vs LANDM Comparison

SCLXW vs LANDM Comparison

Compare SCLXW & LANDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLXW
  • LANDM
  • Stock Information
  • Founded
  • SCLXW N/A
  • LANDM N/A
  • Country
  • SCLXW United States
  • LANDM United States
  • Employees
  • SCLXW 31
  • LANDM N/A
  • Industry
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • LANDM Real Estate Investment Trusts
  • Sector
  • SCLXW Health Care
  • LANDM Real Estate
  • Exchange
  • SCLXW Nasdaq
  • LANDM Nasdaq
  • Market Cap
  • SCLXW N/A
  • LANDM N/A
  • IPO Year
  • SCLXW N/A
  • LANDM N/A
  • Fundamental
  • Price
  • SCLXW $0.13
  • LANDM $24.92
  • Analyst Decision
  • SCLXW
  • LANDM
  • Analyst Count
  • SCLXW 0
  • LANDM 0
  • Target Price
  • SCLXW N/A
  • LANDM N/A
  • AVG Volume (30 Days)
  • SCLXW 4.0K
  • LANDM N/A
  • Earning Date
  • SCLXW 03-07-2025
  • LANDM N/A
  • Dividend Yield
  • SCLXW N/A
  • LANDM N/A
  • EPS Growth
  • SCLXW N/A
  • LANDM N/A
  • EPS
  • SCLXW N/A
  • LANDM N/A
  • Revenue
  • SCLXW $55,152,000.00
  • LANDM N/A
  • Revenue This Year
  • SCLXW N/A
  • LANDM N/A
  • Revenue Next Year
  • SCLXW N/A
  • LANDM N/A
  • P/E Ratio
  • SCLXW N/A
  • LANDM N/A
  • Revenue Growth
  • SCLXW 22.02
  • LANDM N/A
  • 52 Week Low
  • SCLXW $0.18
  • LANDM N/A
  • 52 Week High
  • SCLXW $0.18
  • LANDM N/A
  • Technical
  • Relative Strength Index (RSI)
  • SCLXW 34.31
  • LANDM 55.58
  • Support Level
  • SCLXW $0.11
  • LANDM $24.85
  • Resistance Level
  • SCLXW $0.14
  • LANDM $24.94
  • Average True Range (ATR)
  • SCLXW 0.03
  • LANDM 0.03
  • MACD
  • SCLXW 0.00
  • LANDM 0.00
  • Stochastic Oscillator
  • SCLXW 18.09
  • LANDM 80.84

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About LANDM Gladstone Land Corporation 5.00% Series D Cumulative Term Preferred Stock

Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment. It is focused on the ownership of high-quality farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also own farms that grow certain commodity crops (e.g., corn and beans).

Share on Social Networks: